Claims

Effectiveness evidence for ophthalmic simulators mostly stops at level 2 (contained effects), with isolated exceptions at level 3 (Sophocle) and level 5 (Eyesi for cataract surgery).

Claim · All claims
Evidence · 1 study · review r3 · q3
Currency · newest study 2020 · not yet checked against its sources · not reviewed by a person

Subclaims

Reading the evidence codes

q is the design tier, i the impact, n the sample, and the kind with its r the rigour judged within that kind: what each code means.

This claim: no standardized effect is recorded in observations/ for it yet, so no benchmark reading is possible.

q3 i? Effectiveness ratings for simulator models were mostly limited to level 2 (contained effects), with the Sophocle vitreoretinal simulator shown at level 3 (downstream effects) and the Eyesi at level 5 (target effects) for cataract surgery. → Lee Roxanne 2020

Evidence

Lee Roxanne 2020

Lee Roxanne, Raison Nicholas, Lau Wai Yan, Aydin Abdullatif, Dasgupta Prokar, Ahmed Kamran, Haldar Shreya. (2020). A systematic review of simulation-based training tools for technical and non-technical skills in ophthalmology. Eye. https://doi.org/10.1038/s41433-020-0832-1

q3 · i? · review · r3

The review's synthesis using its adaptation of McGaghie's translational outcome levels, where level 2 is changes in performance in the simulation context, level 3 is behavioural changes in the clinical context, and level 5 is changes on a wider, systemic level such as cost saving or skill retention.

"Effectiveness ratings for simulator models were mostly limited to level 2 (contained effects) with the exception of the Sophocle vitreoretinal surgery simulator, which was shown at level 3 (downstream effects), and the Eyesi at level 5 (target effects) for cataract surgery."

Discussion

Page metadata
Field Value
status review
generated by process:wiki-ingest on 2026-11-01
trust unverified — no one has confirmed this page's content

Frontmatter is the page's machine-readable record — see the Schema & Guide.